[´º½º·±=À±¼±¹Î ±âÀÚ]
´ëÈÁ¦¾àÀº Áö³ 13ÀÏ Áß±¹ ³» ÇÕÀÚȸ»ç(Joint-venture)ÀÎ JHK BiopharmÞä°¡ ´ëÈÁ¦¾à¿¡¼ Á¦Á¶ÇÏ´Â ‘Rivastigmine patch 4.6mg/24h’ ¹× ‘Rivastigmine patch 9.5mg/24hr’¿¡ ´ëÇØ Áß±¹ ±¹°¡¾àÇ°°¨µ¶°ü¸®±¹(NMPA)¿¡ ANDA(Abbreviated New Drug Application, Á¦³×¸¯ Çã°¡)½ÅûÀ» ¿Ï·áÇÏ¿´´Ù°í ¹àÇû´Ù.
JHK BiopharmÞä´Â Áß±¹ ³» ¼±Áø ÀǾàÇ° °³¹ß, ±â¼úµµÀÔ ¹× ½Å¾à°³¹ß ÃßÁø µîÀ» À§ÇØ »óÇÏÀÌ(Shanghai)¿¡ ¼³¸³µÈ Venture Þä·Î ´ëÈÁ¦¾àÀÌ º¸À¯ÇÏ°í ÀÖ´Â TDDS ¹× ODF ±â¼úÀ» ±â¹ÝÀ¸·Î Á¦Ç°È¸¦ ÁøÇà ÁßÀÌ´Ù. ´ëÈÁ¦¾àÀº JHK BiopharmÞäÀÇ ÁöºÐ 25%¸¦ º¸À¯ÇÏ°í ÀÖÀ¸¸ç Áß±¹ ½ÃÀå È®ÀåÀ» À§ÇØ Çù·ÂÇÏ°í ÀÖ´Ù.
´ëÈÁ¦¾à °ü°èÀÚ´Â “±¹³» Rivastigmine ÆÐÄ¡ Á¦Ç° Áß ÃÖÃÊ·Î Ãæ±¹ ³» Ç°¸ñ Çã°¡¸¦ ½ÅûÇÏ¿´À¸¸ç, Çã°¡ ½ÂÀÎÀº 2025³âµµ·Î ¿¹»óÇÏ°í ÀÖ´Ù.”¶ó¸ç “Áß±¹ ¾ËÃ÷ÇÏÀ̸Ӻ´ 2022³â º¸°í(ñé国ä¹尔兹úÙùñø2022报ͱ)¿¡ µû¸£¸é, Áß±¹ÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ ȯÀÚ ¹× ±âŸ Ä¡¸ÅȯÀÚÀÇ ¼ö´Â 1õ¸¸¸íÀ» ³Ñ¾î Àü ¼¼°è ȯÀÚ ¼öÀÇ ¾à 25.5%¸¦ Â÷ÁöÇÏ°í ÀÖÀ¸¸ç, 2050³â±îÁö ±× ȯÀÚ ¼ö°¡ 4õ¸¸ ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î Ãß»êµÈ´Ù“¶ó°í ¹àÇû´Ù.
¶ÇÇÑ, “RivastigmineÀÌ ¾ËÃ÷ÇÏÀ̸ÓÇü Ä¡¸Å ¶Ç´Â ÆÄŲ½¼º´°ú °ü·ÃµÈ Ä¡¸ÅÀÇ ´ëÁßÀû Ä¡·á¿¡ »ç¿ëµÊÀº ¹°·Ð, ÆÐÄ¡Á¦·Î¼ ¿¬ÇÏÀå¾Ö ȯÀÚ(¸ñ ³Ñ±è ¾î·Á¿ò)ÀÇ »ç¿ë ÆíÀǼº°ú º¸È£ÀÚµéÀÇ Åõ¿© ÃßÀû °ü¸®°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ Áß±¹ ½ÃÀå ³» ¹ÝÀÀÀÌ ÁÁÀ» °ÍÀ¸·Î ±â´ëÇÏ°í ÀÖ´Ù.”¶ó°í ¹àÇû´Ù.
´ëÈÁ¦¾àÀÇ ‘Rivastimgne Patch’ Á¦ÇüÀº °¡±³Á¦(Cross-linking agent)¸¦ »ç¿ëÇÏÁö ¾Ê°í, Ư¼ö ÷°¡Á¦¸¦ »ç¿ëÇÏ¿© ÇǺΠÀڱصµ¸¦ ³·Ãß¾úÀ¸¸ç, ¿ÜºÎ Á¢Âø ÃþÀ» ´õÇÏ¿© Ÿ Á¦³×¸¯(Generic) ÀǾàÇ°ÀÇ Å׵θ® ¾à¾× ´©Ãâ Çö»ó µîÀ» °³¼±ÇÑ Ç°¸ñÀÌ´Ù.
ÇÑÆí, ´ëÈÁ¦¾àÀº Áö³ 2017³â 9¿ù ÇÏÀÌÇã ¹ÙÀÌ¿ÀÆĸ¶(Haihe Biopharma)¿¡ ±â¼ú¼öÃâÇÑ ¸®Æ÷¶ô¼¿¾×(DHP107/RMX3001)ÀÌ 2022³â 9¿ù À§¾Ï¿¡ ´ëÇÑ Ç°¸ñÇã°¡¸¦ ½Åû(NDA)ÇÏ¿´À¸¸ç, 2018³â 6¿ù ±¹¾àÄ¡±º(½Éõ)Á¦¾à(国药öÈÏÖ(ä¢圳)ð¤药)¿¡ 1000¾ï¿ø´ë ´ÜÀÏ°ø±Þ°è¾àÀ» ü°áÀ» ÁøÇàÇÑ ¾Æ¸»¸®¾È ÇÊ·¯¿¡ ´ëÇØ 2023³â 4¿ù Ç°¸ñÇã°¡ ½ÅûÀ» ÁøÇàÇÏ´Â µî, Áß±¹½ÃÀåÀ» °Ü³ÉÇÑ È°¹ßÇÑ ¿µ¾÷È°µ¿À» Àü°³ÇÏ¿© ÆĸÓ¡ ¸¶ÄÏ(Pharmerging market) ÁøÃâ¿¡ ³ª¼°í ÀÖ´Ù.
À±¼±¹Î ±âÀÚ news114@newsrun.co.kr
À±¼±¹Î ±âÀÚ news114@newsrun.co.kr
<ÀúÀÛ±ÇÀÚ © ´º½º·±, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>